http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-330304-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-88
filingDate 1966-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-330304-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF ISOQUINOLINE.
abstract Process for the preparation of isoquinoline derivatives of general formula I ** (See formula) ** wherein R means an alkyl radical having from 1 to 4 carbon atoms inclusive, a phenyl radical, a thienyl radical, or a benzyl radical, which may optionally be substituted on the benzene ring by a halogen atom, each of which R1 and R2 means a hydrogen atom or an alkoxy radical having 1 to 4 carbon atoms inclusive, provided that R1 and R2 must not be the same, and n means 1 or 2, characterized in that a compound of general formula is reduced II, ** (See formula) ** wherein R, R1, and R2 and n have the meaning above, or a quaternary ammonium compound of general formula III ** (See formula) ** wherein R1, R2 and n have the above-indicated meaning, and x- means an anion of chlorine, bromine or iodine, is reacted with a compound of general formula IV R-Mg-X IV wherein R has the meaning above and X signifies a chlorine, bromine or iodine atom, and the resulting complex is hydrolyzed. (Machine-translation by Google Translate, not legally binding)
priorityDate 1965-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420312335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456414897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260

Total number of triples: 30.